A case of anti-NMDAR encephalitis presented hypotensive shock during plasma exchange.
Abstract
We are reporting on a case of pediatric anti-NMDAR encephalitis with autonomic instability. The patient showed little response to first-line treatment of steroid and IVIG. We initiated plasma exchange, also a first-line treatment. This worsened his autonomic instability, resulting in hypotensive shock. He responded well to rituximab and cyclophosphamide, second-line therapies. Anti-NMDAR encephalitis is often accompanied by autonomic instability. Our and other reported cases, raise the question of plasma exchange as a first-line therapy for pediatric NMDAR encephalitis, which is frequently accompanied by autonomic instability. Plasma exchange should be performed cautiously in such patients.
Department of Pediatrics, Jichi Medical University, Japan.Department of Pediatrics, Jichi Medical University, Japan. Electronic address: mon4441977319@jichi.ac.jp.Department of Pediatrics, Jichi Medical University, Japan.National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.Department of Pediatrics, Jichi Medical University, Japan. MeSH
Anti-N-Methyl-D-Aspartate Receptor EncephalitisBrainChildCyclophosphamideHumansHypotensionImmunosuppressive AgentsImmunotherapyMalePlasma ExchangePlasmapheresisRituximabShockTreatment Outcome
Pub Type(s)
Case Reports
Journal Article